Edition:
United Kingdom

Insider Trading: Zealand Pharma A/S (ZEAL.OQ)

ZEAL.OQ on NASDAQ Stock Exchange Global Select Market

19.05USD
24 Apr 2019
Change (% chg)

-- (--)
Prev Close
$19.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,097
52-wk High
$20.00
52-wk Low
$11.30

All Insider Trades

Institutional Holders

% Shares Owned: 35.89%
# of Holders: 53
Total Shares Held: 11,368,890
3 Mo. Net Change: -87,403
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 9
# Reduced Positions: 12
# Net Buyers: -3

Officers & Directors

Name Age Since Current Position

Alf Nicklasson

64 2015 Independent Chairman of the Board

Adam Steensberg

45 2019 Executive Vice President, Chief Medical and Development Officer (CMDO)

Kirsten Drejer

2019 Independent Vice Chairman of the Board

Ivan Moeller

46 2018 Senior Vice President, Technical Development & Operations

Andrew Parker

53 2017 Executive Vice President, Chief Scientific Officer

Marino Garcia

51 2018 Senior Vice President, Corporate and Business Development

Jeffrey Berkowitz

52 2019 Director

Bernadette Connaughton

2019 Director

Hanne Heidenheim Bak

65 2016 Director, Employee Representative

Leonard Kruimer

61 2019 Director

Jens Stenvang

64 2014 Director, Employee Representative

Alain Munoz

70 2007 Independent Director

Michael Owen

67 2012 Independent Director